Use of gemcitabine in non-small-cell lung cancer

Question: What is the role of gemcitabine (Gemzar®), alone or in combination, in the treatment of patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)? Perspectives: Evidence was selected and reviewed by one member of the Lung Cancer Disease Site Group (Lung DSG) of the Cancer Care Ontario Practice Guidelines Initiative (CCOPGI) and by methodologists. The present practice guideline report has been reviewed and …